About IAPACEducationAdvocacyConferencesWhat's NewPublicationsJoin IAPACContact UsLinksMain Page

Norvir Advisory


The Norvir Switch, by Mark Schoofs


Interview with Eugene Sun, MD, by Charles Farthing, MD


Presentation 1, Norvir Community Update, Eugene Sun, MD


Presentation 2, Norvir Community Update, Steve Byrn, PhD


Presentation 3, Norvir Community Update, Steve Lichter, MD


Presentation 4, Norvir Community Update, Rob Dintruff, Robert Dintruff, Marketing Manager, Abbott International


Abbott News Releases

Abbott Announces Difficulty Manufacturing Norvir (Ritonavir) Capsules - Company Plans to Substitute With Liquid Formulation

Urgent Message and Questions & Answers for Patients Regarding Abbott's Ritonavir (Norvir)

Notice: This is an IAPAC initiative that is under the sole direction of the IAPAC Norvir Advisory Committee. Contents of the Norvir Advisory section of the IAPAC Web site are subject to the approval of the chair of the advisory committee and will reflect the recommendations of the committee members. Abbott Laboratories has no input in the content of the Norvir Advisory section of the IAPAC Web site.